Prediction of the pharmacokinetics and adverse events of nab-paclitaxel in patients with pancreatic cancer by magnetic resonance imaging
Not Applicable
Recruiting
- Conditions
- nresectable locally advanced pancreatic cancer or metastatic pancreatic cancer
- Registration Number
- JPRN-UMIN000026180
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Hypersensitivity to Gd-EOB-DTPA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between the pretreatment parenchymal hepatic enhancement effect of Gd-EOB-DTPA MRI and the plasma paclitaxel concentration.
- Secondary Outcome Measures
Name Time Method The relationship among enhancement effect of Gd-EOB-DTPA, development of peripheral neuropathy during chemotherapy, and gene polymorphisms of hepatic transporter